Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PHAGOCYTOSIS: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PHAGOCYTOSIS is a gene implicated in neurodegeneration research. Key relationships include: activates, associated with, interacts with. Associated with ALS, ALZHEIMER, ALZHEIMER'S. Connected to 963 entities in the SciDEX knowledge graph.
| Gene Symbol | PHAGOCYTOSIS |
| Aliases | phagocytosis |
| Associated Diseases | ALS, ALZHEIMER'S DISEASE, Aging, Alzheimer, Alzheimer Disease |
| Known Drugs/Compounds | RAPAMYCIN, MELATONIN |
| Interactions | MITOPHAGY, ALZHEIMER'S DISEASE, CYTOKINES, AKT, ASTROCYTES, INFLAMMATION |
| KG Connections | 1927 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
graph TD
PHAGOCYTOSIS["PHAGOCYTOSIS"] -->|"activates"| Dementia["Dementia"]
PHAGOCYTOSIS["PHAGOCYTOSIS"] -->|"activates"| Inflammation["Inflammation"]
PHAGOCYTOSIS["PHAGOCYTOSIS"] -->|"activates"| Alzheimer["Alzheimer"]
PHAGOCYTOSIS["PHAGOCYTOSIS"] -->|"activates"| Als["Als"]
PHAGOCYTOSIS["PHAGOCYTOSIS"] -->|"activates"| Neuroinflammation["Neuroinflammation"]
PHAGOCYTOSIS["PHAGOCYTOSIS"] -->|"activates"| Ms["Ms"]
MICROGLIA["MICROGLIA"] -->|"associated"| PHAGOCYTOSIS["PHAGOCYTOSIS"]
MSR1["MSR1"] -->|"regulates"| PHAGOCYTOSIS["PHAGOCYTOSIS"]
BAG3["BAG3"] -->|"activates"| PHAGOCYTOSIS["PHAGOCYTOSIS"]
C1Q["C1Q"] -->|"activates"| PHAGOCYTOSIS["PHAGOCYTOSIS"]
style PHAGOCYTOSIS fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| NEUROINFLAMMATION | activates | gene | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Als | activates | disease | 1.00 |
| Neuroinflammation | activates | disease | 1.00 |
| Phagocytosis | activates | pathway | 1.00 |
| Tumor | activates | disease | 1.00 |
| Phagocytosis | regulates | pathway | 1.00 |
| AUTOPHAGY | associated_with | gene | 1.00 |
| Autophagy | associated_with | pathway | 1.00 |
| Phagocytosis | associated_with | pathway | 1.00 |
| Als | regulates | disease | 1.00 |
| Als | associated_with | disease | 1.00 |
| Neurodegeneration | activates | disease | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| MICROGLIA | activates | gene | 1.00 |
| Cancer | activates | disease | 1.00 |
| Immune Response | activates | pathway | 1.00 |
| Phagocytosis | implicated_in | pathway | 1.00 |
| Als | implicated_in | disease | 1.00 |
| Inflammation | implicated_in | disease | 1.00 |
| Neurodegeneration | implicated_in | disease | 1.00 |
| Phagocytosis | inhibits | pathway | 1.00 |
| Complement | activates | pathway | 1.00 |
| MICROGLIA | regulates | gene | 1.00 |
| MICROGLIA | implicated_in | gene | 1.00 |
| Alzheimer | activates | disease | 0.95 |
| Alzheimer | regulates | disease | 0.95 |
| Aging | regulates | disease | 0.95 |
| Stroke | activates | disease | 0.95 |
| Inflammation | associated_with | disease | 0.95 |
| Alzheimer | implicated_in | disease | 0.95 |
| Alzheimer | therapeutic_target | disease | 0.95 |
| Infection | activates | disease | 0.95 |
| AKT | activates | gene | 0.90 |
| Nf-Κb | activates | pathway | 0.90 |
| Phagocytosis | expressed_in | pathway | 0.90 |
| Aging | activates | disease | 0.85 |
| Alzheimer | inhibits | disease | 0.85 |
| Als | therapeutic_target | disease | 0.85 |
| Alzheimer | associated_with | disease | 0.85 |
| Als | interacts_with | disease | 0.85 |
| Neuroinflammation | implicated_in | disease | 0.85 |
| Autophagy | activates | pathway | 0.80 |
| Apoptosis | activates | pathway | 0.80 |
| Inflammasome | activates | pathway | 0.80 |
| Oxidative Phosphorylation | activates | pathway | 0.80 |
| ALZHEIMER | activates | gene | 0.80 |
| GENES | activates | gene | 0.80 |
| STROKE | activates | gene | 0.80 |
| MICROGLIA | associated_with | gene | 0.80 |
| Source | Relation | Type | Str |
|---|---|---|---|
| C1Q | activates | protein | 1.00 |
| LC3 | associated_with | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| INFLAMMATION | implicated_in | gene | 1.00 |
| INFLAMMATION | regulates | gene | 1.00 |
| NEURODEGENERATION | activates | gene | 1.00 |
| LC3 | activates | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| TREM2 | activates | gene | 1.00 |
| SPP1 | regulates | entity | 0.95 |
| MICROGLIA | associated_with | gene | 0.90 |
| NEURODEGENERATIVE DISEASES | activates | gene | 0.90 |
| APOPTOSIS | activates | gene | 0.90 |
| AUTOPHAGY | associated_with | gene | 0.90 |
| CYTOKINES | activates | gene | 0.90 |
| NEURODEGENERATION | implicated_in | gene | 0.90 |
| ALZHEIMER | implicated_in | gene | 0.90 |
| ALZHEIMER'S DISEASE | implicated_in | gene | 0.90 |
| COMPLEMENT | activates | gene | 0.90 |
| ALZHEIMER | therapeutic_target | gene | 0.90 |
| ALZHEIMER'S DISEASE | therapeutic_target | gene | 0.90 |
| MICROGLIA | involved_in | entity | 0.85 |
| TREM2 R47H | increases | gene_variant | 0.80 |
| TREM2 | mediates | gene | 0.80 |
| TET2-mutant myeloid cells | enhances | cell_type | 0.80 |
| GENES | activates | gene | 0.80 |
| INFLAMMATION | associated_with | gene | 0.80 |
| ALZHEIMER | regulates | gene | 0.80 |
| ALZHEIMER'S DISEASE | regulates | gene | 0.80 |
| ATG5 | associated_with | gene | 0.80 |
| MSR1 | regulates | gene | 0.72 |
| BAG3 | activates | protein | 0.72 |
| PARKINSON'S DISEASE | regulates | gene | 0.70 |
| TREM2 | regulates | gene | 0.70 |
| CANCER | therapeutic_target | gene | 0.70 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.70 |
| TREM2 | associated_with | gene | 0.70 |
| ALZHEIMER'S DISEASE | activates | gene | 0.70 |
| NF-ΚB | expressed_in | gene | 0.70 |
| PARKINSON'S DISEASE | activates | gene | 0.70 |
| GENES | associated_with | gene | 0.70 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.70 |
| AMYLOID | associated_with | gene | 0.70 |
| MAP1LC3B | associated_with | gene | 0.70 |
| INFLAMMATION | expressed_in | gene | 0.70 |
| ROS | implicated_in | gene | 0.70 |
| CYTOKINES | implicated_in | gene | 0.70 |
| SYNAPTIC PRUNING | activates | gene | 0.70 |
| GENES | implicated_in | gene | 0.70 |
| NEURODEGENERATIVE DISEASES | implicated_in | gene | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| SASP-Driven Microglial Metabolic Reprogramming in Synaptic P | 0.638 | neurodegeneration | Senolytic therapy for age-related neurod |
| Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in | 0.458 | Alzheimer's disease | TREM2 agonism vs antagonism in DAM micro |
| Soluble TREM2 (sTREM2) as Therapeutic Mimic — Decoupling Pha | 0.452 | Alzheimer's disease | TREM2 agonism vs antagonism in DAM micro |
| Microglial TREM2-Mediated Tau Phagocytosis Impairment | 0.441 | neuroscience | Circuit-level neural dynamics in neurode |
Scientific analyses that reference this entity
No analyses mention this entity
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213] | Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei | Neuron | 2026 | 0 |
| Role of TREM2 in neuroinflammation. [PMID:41213496] | Abdulkhaliq AA, Alasiri G, Almoghrabi Y, | Exp Neurol | 2026 | 0 |
| Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649] | Zhang J, St Pierre Schneider B, Muguerza | Am J Physiol Endocrinol Metab | 2026 | 0 |
| Diankuang Mengxing Decoction exerts neuroprotective effects in post-stroke depre [PMID:41534750] | Yang X, Zhao Y, Liu W, Feng J, Wu X et a | J Ethnopharmacol | 2026 | 0 |
| Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvir [PMID:41576929] | Mateus-Tique J, Lakshmi A, Singh B, Iyer | Cancer Cell | 2026 | 0 |
| Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] | Li X, Tang X, Zeng J, Duan L, Hou Z et a | Cell | 2026 | 0 |
| TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393] | Feiten AF, Dahm K, Schlepckow K, van Len | Nat Commun | 2026 | 0 |
| Large-scale single-cell analysis and in silico perturbation reveal dynamic evolu [PMID:41617928] | Xia P, Shuang S, Fu D, Liu L, Yang D et | NPJ Precis Oncol | 2026 | 0 |
| Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant [PMID:41720086] | Zhao Q, Huang R, Wang C, Hu J, Nie R et | Cancer Cell | 2026 | 0 |
| TREM2 deficiency delays postnatal microglial maturation and synaptic pruning, le [PMID:41930604] | Yang HC, Deng YS, Zhang J, Zhang T, Song | J Alzheimers Dis | 2026 | 0 |
| Hierarchical Targeting of TREM2(+) Myeloid Cells via Acid-Triggered OMVs Reprogr [PMID:41945876] | Chen F, Xue Y, Ma X, Chen L, Shao Z et a | Adv Sci (Weinh) | 2026 | 0 |
| Correction to "A Strategy Involving Microporous Microneedles Integrated with CAR [PMID:41952643] | Unknown | Advanced materials (Deerfield | 2026 | 0 |
| TREM2 in neurodegeneration and diseases. [PMID:41792456] | ["Abdulkhaliq A", "Alasiri G", "Kim B", | Molecular psychiatry | 2026 | 0 |
| Alzheimer's Disease as a Disorder of Neuroimmune Dysregulation. [PMID:41745721] | Aranda-Abreu GE, Rojas-Durán F, Hernánde | Neurology international | 2026 | 0 |
| Molecular mechanism of Alzheimer's disease using integrated multi-omics. [PMID:41907842] | Alhusaini M, Mussa BM, Ilce BY, Alhaj H, | Frontiers in aging neuroscienc | 2026 | 0 |
| Obesity-induced pyroptotic adipocyte death leads to TREM2-dependent macrophage d [PMID:41509917] | Choi C, Lee J, Park G, Namgoong S, Lee Y | iScience | 2026 | 0 |
| Viral and non-viral cellular therapies for neurodegeneration. [PMID:41585268] | ["Srivastav Jyotsna", "Sharma Sachin"] | Frontiers in medicine | 2025 | 0 |
| Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy. [PMID:20301376] | Adam MP, Bick S, Mirzaa GM, Pagon RA, Wa | 1993 | 0 |